CreditReports.dk
HomeScreen companies

CONTERA PHARMA A/S Financials, key figures and credit report

CVR number: 33062214 Established 2010 Industry: 72 Scientific research and development
Company contact details
Venlighedsvej 4, 2970 Hørsholm ts@conterapharma.com tel: 31186611 www.conterapharma.com
Gross profit 20 632.3 kDKK FY 2025 +138.1% vs 2024
EBIT -5 983.7 kDKK FY 2025 +92.1% vs 2024
Net debt -84 445.3 kDKK FY 2025 -103.6% vs 2024
Quick ratio 5.0 FY 2025 -1 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit-24 154.46-45 152.32-58 993.91-54 083.9520 632.31
Employee benefit expenses-12 111.66-12 905.55-17 993.65-19 858.78-24 803.44
Other operating expenses-41.99
Total depreciation- 126.06-4 025.81-1 272.11-1 641.65-1 812.55
EBIT-36 392.18-62 083.69-78 259.67-75 626.37-5 983.68
Other financial income36.42328.742 028.671 339.98527.07
Other financial expenses- 225.07- 613.38- 589.30- 427.35- 606.04
Pre-tax profit-36 580.83-62 368.33-76 820.30-74 713.74-6 062.66
Income taxes5 061.995 500.005 500.005 500.001 278.88
Net earnings-31 518.83-56 868.33-71 320.30-69 213.74-4 783.78

Assets (kDKK)

2021
2022
2023
2024
2025
Intangible assets total
Machinery and equipment364.395 302.067 881.577 195.606 332.95
Tangible assets total364.395 302.067 881.577 195.606 332.95
Investments total441.92918.90664.43586.45586.45
Long term receivables total
Inventories total
Current trade debtors1 275.42
Current amounts owed by group member comp.2 256.881 428.77
Prepayments and accrued income415.7612 211.587 717.823 665.053 606.16
Current other receivables920.243 272.721 146.183 738.725.00
Current deferred tax assets5 183.735 524.445 573.985 521.191 299.68
Short term receivables total6 519.7321 008.7416 694.8714 353.726 186.26
Cash and bank deposits159 886.5788 513.1367 127.7141 474.0184 445.28
Cash and cash equivalents159 886.5788 513.1367 127.7141 474.0184 445.28
Balance sheet total (assets)167 212.61115 742.8392 368.5863 609.7897 550.95

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital621.44621.44652.691 403.192 708.16
Retained earnings194 339.47162 820.64156 965.65122 198.7581 547.43
Profit of the financial year-31 518.83-56 868.33-71 320.30-69 213.74-4 783.78
Shareholders equity total163 442.08106 573.7586 298.0454 388.1979 471.80
Non-current liabilities total
Current trade creditors1 897.708 373.803 355.577 755.284 324.34
Short-term deferred tax liabilities69.73
Other non-interest bearing current liabilities1 803.09795.282 714.961 466.3113 754.81
Current liabilities total3 770.529 169.086 070.539 221.5918 079.15
Balance sheet total (liabilities)167 212.61115 742.8392 368.5863 609.7897 550.95
Page generated